Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
3 Largest selling pharmaceutical products of 2015. 4 Best selling pharmaceuticals of 2013. ... Genentech. 7,115 1,456 6 Insulin glargine: Lantus Biologic Diabetes ...
Genentech previously said the use of the drug in the indication accounts for a fraction of its overall revenue. The U.S. Food and Drug Administration had granted accelerated approval to Gavreto in ...
About Genentech. Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or ...
Saying that biotech Genentech had unpaid royalties due it going all the way back to 2007, PDL BioPharma announced this morning that it has filed for arbitration against the division of Roche Holdings.
The US Food and Drug Administration (FDA) awarded marketing approval to Genentech in August 2020. The FDA earlier granted the application for risdiplam fast track, priority review, and orphan drug designations. [6] [9] [11] Genentech was also awarded a rare pediatric disease priority review voucher. [6]
Efalizumab (brand name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis.As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection.